COVID-19 Resources for Medical Students and Residents
Our Sincerest Thanks We’re proud to recognize these industry supporters for their year-round support of the American Society of Anesthesiologists®.
Our Sincerest Thanks We’re proud to recognize these industry supporters for their year-round support of the American Society of Anesthesiologists®.
FAER is pleased to announce Sean Mackey, MD, PhD, Redlich Professor and Chief of the Division of Pain Medicine in the Department of Anesthesiology, Perioperative,…
Glucagon-like peptide-1 (GLP-1) receptor agonists are approved by the Food and Drug Administration for treatment of type 2 diabetes mellitus and cardiovascular risk reduction in…
Go behind the scenes with Dr. Fernandez in this podcast and ASA Monitor article (PDF) that describes her desire to “create a kind of professional…
On December 18, 2023, the Departments of Health and Human Services, Labor, and Treasury (the Departments) released the No Surprises Act Independent Dispute Resolution (IDR)…
Glucagon-like peptide-1 (GLP-1) receptor agonists are approved by the Food and Drug Administration for treatment of type 2 diabetes mellitus and cardiovascular risk reduction in…
Go behind the scenes with Dr. Fernandez in this podcast and ASA Monitor article (PDF) that describes her desire to “create a kind of professional…
Scope out PeRLS anesthesia-centric ACLS at the annual meeting. Engage in hands-on management of simulated perioperative emergencies, review current guidelines, and more. Keep care team…
With the growing popularity of medications like Ozempic® (semaglutide), Trulicity® (dulaglutide), and other glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of type 2 diabetes…
Glucagon-like peptide-1 (GLP-1) receptor agonists are approved by the Food and Drug Administration for treatment of type 2 diabetes mellitus and cardiovascular risk reduction in…
Medical Students: Scroll down the page to access all of the events. Click on each column heading to sort the events. Register by following the…